DE602004002292D1 - Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung - Google Patents

Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung

Info

Publication number
DE602004002292D1
DE602004002292D1 DE602004002292T DE602004002292T DE602004002292D1 DE 602004002292 D1 DE602004002292 D1 DE 602004002292D1 DE 602004002292 T DE602004002292 T DE 602004002292T DE 602004002292 T DE602004002292 T DE 602004002292T DE 602004002292 D1 DE602004002292 D1 DE 602004002292D1
Authority
DE
Germany
Prior art keywords
superoxide dismutase
compositions contain
lipoxygenase inhibitor
allergy
lipoxygenase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004002292T
Other languages
English (en)
Other versions
DE602004002292T2 (de
Inventor
Bernard Dugas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isocell SA
Original Assignee
Isocell SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell SA filed Critical Isocell SA
Publication of DE602004002292D1 publication Critical patent/DE602004002292D1/de
Application granted granted Critical
Publication of DE602004002292T2 publication Critical patent/DE602004002292T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DE602004002292T 2003-03-28 2004-03-19 Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung Expired - Lifetime DE602004002292T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0303865A FR2852847B1 (fr) 2003-03-28 2003-03-28 Composition renfermant une superoxyde dismutase et un inhibiteur de la 5-lipoxygenase selectionne et applications
FR0303865 2003-03-28
PCT/FR2004/000682 WO2004087119A2 (fr) 2003-03-28 2004-03-19 Compositions renfermant une superoxyde dismutase et un inhibiteur de la 5-lipoxygenase selectionne et applications

Publications (2)

Publication Number Publication Date
DE602004002292D1 true DE602004002292D1 (de) 2006-10-19
DE602004002292T2 DE602004002292T2 (de) 2007-09-13

Family

ID=32947258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004002292T Expired - Lifetime DE602004002292T2 (de) 2003-03-28 2004-03-19 Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung

Country Status (6)

Country Link
EP (1) EP1608351B1 (de)
KR (1) KR20050119083A (de)
AT (1) ATE338543T1 (de)
DE (1) DE602004002292T2 (de)
FR (1) FR2852847B1 (de)
WO (1) WO2004087119A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1993593B1 (de) 2006-03-15 2015-08-26 Isocell S.A. Sod und peptidfragmente auf gliadinbasis enthaltende pharmazeutische zusammensetzungen
FR2899065B1 (fr) * 2006-03-29 2008-07-18 Alain Dreyer Brevets Et Dev So Sod micro encapsulee et adsorbee sur support mineral et vegetal destinee a l'alimentation animale
KR100852864B1 (ko) * 2007-04-13 2008-08-18 보령메디앙스 주식회사 초록입 홍합(Ｐｅｒｎａ Ｃａｎａｌｉｃｕｌｕｓ.)추출물을 함유하는 화장료 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695456A (en) * 1984-10-31 1987-09-22 Centerchem, Inc. Method for alleviating skin irritation by formulations containing superoxide dismutase
EP0366869A3 (de) * 1988-10-17 1991-06-12 Lycon Ag Bakteriostatische,Bakterizide und Pilzabweisende Zusammensetzung und Verwendung derselben
LU87766A1 (fr) * 1990-07-20 1992-03-11 Oreal Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
US5561052A (en) * 1992-06-18 1996-10-01 Koike; Katsumasa Process for detecting oxidized lipids and process for forming oxidized lipids

Also Published As

Publication number Publication date
ATE338543T1 (de) 2006-09-15
FR2852847A1 (fr) 2004-10-01
WO2004087119A2 (fr) 2004-10-14
WO2004087119A3 (fr) 2004-12-09
KR20050119083A (ko) 2005-12-20
EP1608351A2 (de) 2005-12-28
EP1608351B1 (de) 2006-09-06
FR2852847B1 (fr) 2006-09-08
DE602004002292T2 (de) 2007-09-13

Similar Documents

Publication Publication Date Title
SE0102315D0 (sv) Compounds
WO2006102610A3 (en) Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
NO20092639L (no) 4-fenyl-6-(2,2,2-trifluor-1-fenyletoksy)pynmidinbaserte forbindelser og anvendelser derav
WO2004052280A3 (en) Anti-angiogenic compounds and their use in cancer treatment
AU2002258066A1 (en) Dermatological and cosmetic compositions
HK1074592A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
TW200612910A (en) Medicaments comprising carbonyl compounds, and the use thereof
IL216579A0 (en) Aminocyclohexyl ether derivatives and pharmaceutical compositions containing the same
WO2004006858A3 (en) Compounds, compositions, and methods employing same
DE60228761D1 (de) Pharmazeutische zusammensetzung (kit) enthaltend dihydropyridinonverbindungen und eine verbindung mit immunmodulatorischer (oder antiinflammatorischer) wirkung und ihre verwendung
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
WO2007028022A3 (en) Novel compounds as p2x7 modulators and uses thereof
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
PL1809288T3 (pl) Zastosowanie pochodnych 1,4-bis-(3-aminoalkilo)piperazyny do leczenia chorób neurodegeneracyjnych
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004060890A8 (en) 2-oxopyridin-3-yl thia (di) azole derivates for use in the treatment of cell proliferation and apoptosis related diseases
MXPA05005314A (es) Compuestos de lapacona novedosos y metodos de uso de los mismos.
MX2023001997A (es) Compuestos biciclicos, composiciones y usos de los mismos.
WO2009130615A3 (de) Verwendung von deuteriumoxid als elastase-inhibitor
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
DE602004002292D1 (de) Zusammensetzungen enthaltend eine superoxiddismutase, einen 5-lipoxygenase-inhibitor sowie deren verwendung
DE602004019500D1 (en) 4-substituirte-5-cyano-1h-pyrimidin-6-(th)iones als als gsk-3-hemmer
DE60311665D1 (de) Pharmazeutische zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: VONNEMANN, KLOIBER & KOLLEGEN, 20099 HAMBURG